Effect of a Spice Blend on Cardiovascular Risk Factors and Diet Satisfaction
The Effect of Chronic Consumption of Popular Spices on Risk Factors for Cardiovascular Disease (CVD), Inflammation & Immune Function, and Diet Satisfaction
1 other identifier
interventional
71
1 country
1
Brief Summary
This study is a randomized 3-period crossover, controlled feeding study designed to evaluate the effects of the most commonly consumed spices in the U.S. on CVD risk factors, inflammation \& immune function, and diet satisfaction in participants at risk for CVD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2017
CompletedFirst Submitted
Initial submission to the registry
February 13, 2017
CompletedFirst Posted
Study publicly available on registry
February 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 26, 2020
CompletedAugust 18, 2023
August 1, 2023
3.1 years
February 13, 2017
August 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in lipid/lipoprotein profile
Total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides
Change from baseline in lipid/lipoprotein profile at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
Secondary Outcomes (13)
Central blood pressure
Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
Brachial blood pressure
Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
Augmentation index
Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
Pulse wave velocity
Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
HDL function
Change from baseline in lipid/lipoprotein profile at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
- +8 more secondary outcomes
Other Outcomes (3)
Change in LDL oxidation
Change from baseline in LDL oxidation at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
Change in composition of the gut microbiome
Change from baseline in composition of the gut microbiome at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
Change in urinary isoprostanes
Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)
Study Arms (3)
SD-Low
ACTIVE COMPARATORAverage American Diet (32% of calories from fat, 11% of calories from saturated fat and 3400mg sodium/day) with a minimal amount of spices (\<1g/day for all diets). Post prandial test meal will be contain minimal amounts of spice.
SD-Mod
EXPERIMENTALAverage American Diet (32% of calories from fat, 11% of calories from saturated fat and 3400mg sodium/day) with a moderate amount of spices (\~3g/day in the 2100kcal diet). Post prandial test meal will be contain a moderate amount of spice.
SD-Culinary
EXPERIMENTALAverage American Diet (32% of calories from fat, 11% of calories from saturated fat and 3400mg sodium/day) with a culinary dose of spices (6g/day in the 2100kcal diet). Post prandial test meal will be contain a culinary amount of spice.
Interventions
Average American diet with different levels of spices
Eligibility Criteria
You may qualify if:
- overweight or obese (25-35kg/m2)
- non-smoking
- male or female
- waist circumference \>= 94cm for men and \>=80cm for women
- at least one other of the following: LDL- cholesterol \>130mg/dL; CRP \>1mg/L; triglycerides \>=150mg/dL; HDL \<40mg/dL for men or \<50mg/dL for women; systolic blood pressure \>= 130mmHg or diastolic \>= 85mmHg; fasting glucose \>=100mg/dL
You may not qualify if:
- diabetes (fasting glucose \>126mg/dL)
- hypertension (systolic blood pressure \>160mmHg or diastolic blood pressure \>100mmHg)
- prescribed anti-hypertensive or glucose lowering drugs
- established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease
- use of cholesterol/lipid lowering medication or supplementation (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals
- pregnancy or lactation
- weight loss of \>=10% of body weight within the 6 months prior to enrolling in the study
- vegetarianism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Penn State Universitylead
- McCormick Science Institutecollaborator
Study Sites (1)
Penn State University
University Park, Pennsylvania, 16802, United States
Related Publications (3)
Petersen KS, Anderson S, Chen See JR, Leister J, Kris-Etherton PM, Lamendella R. Herbs and Spices Modulate Gut Bacterial Composition in Adults at Risk for CVD: Results of a Prespecified Exploratory Analysis from a Randomized, Crossover, Controlled-Feeding Study. J Nutr. 2022 Nov;152(11):2461-2470. doi: 10.1093/jn/nxac201. Epub 2022 Sep 2.
PMID: 36774112DERIVEDOh ES, Petersen KS, Kris-Etherton PM, Rogers CJ. Four weeks of spice consumption lowers plasma proinflammatory cytokines and alters the function of monocytes in adults at risk of cardiometabolic disease: secondary outcome analysis in a 3-period, randomized, crossover, controlled feeding trial. Am J Clin Nutr. 2022 Jan 11;115(1):61-72. doi: 10.1093/ajcn/nqab331.
PMID: 34601551DERIVEDPetersen KS, Davis KM, Rogers CJ, Proctor DN, West SG, Kris-Etherton PM. Herbs and spices at a relatively high culinary dosage improves 24-hour ambulatory blood pressure in adults at risk of cardiometabolic diseases: a randomized, crossover, controlled-feeding study. Am J Clin Nutr. 2021 Dec 1;114(6):1936-1948. doi: 10.1093/ajcn/nqab291.
PMID: 34510174DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Penny Kris-Etherton, PhD
Penn State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2017
First Posted
February 27, 2017
Study Start
January 25, 2017
Primary Completion
February 26, 2020
Study Completion
February 26, 2020
Last Updated
August 18, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share